The GLP-1 stall guide addresses the weight loss plateau scenario, which is distinct from the tolerability scenario but sometimes leads women to make dose changes for the wrong reasons
References: Ozempic list price explanation, Novo Nordisk (2024) Patient Assistance Program (PAP), Novo Nordisk (2024) Wegovy list price explanation, Novo Nordisk (2024) Rybelsus list price explanation, Novo Nordisk (2024) Semaglutide market report, Grand View Research (2024) FDA clarifies policies as GLP-1 supply stabilizes, FDA (2024) Compounded semaglutide: how to better ensure its safety, Medscape (2024) Illicit compounding position, Novo Nordisk (2025)
I also served as superintendent in Hamilton County, Tennessee
Your individual case documentation, not your position in the aggregate, determines your recovery